Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.
about
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsPrognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis.Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma.BAG3 and HIF-1 α coexpression detected by immunohistochemistry correlated with prognosis in hepatocellular carcinoma after liver transplantation.The role of hypoxia inducible factor-1 in hepatocellular carcinoma.Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection.Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic targetHypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgeryArtemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.Expression of hypoxia-inducible factor 3α in hepatocellular carcinoma and its association with other hypoxia-inducible factorsEnhanced angiogenesis, hypoxia and neutrophil recruitment during Myc-induced liver tumorigenesis in zebrafishIdentification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysisViruses as key regulators of angiogenesis.Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.Novel therapeutic targets and predictive markers for hepatocellular carcinoma.Hypoxia inducible factors in hepatocellular carcinomaEpigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.Roles of Copper in Hepatocarcinogenesis via the Activation of Hypoxia-Inducible Factor-1α.REST mediates resolution of HIF-dependent gene expression in prolonged hypoxia.Longer warm ischemia can accelerate tumor growth through the induction of HIF-1α and the IL-6-JAK-STAT3 signaling pathway in a rat hepatocellular carcinoma model.Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1α expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma.Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma.Markers of mechanical asphyxia: immunohistochemical study on autoptic lung tissues.Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.Pulmonary function impairment predicted poor prognosis of patients with hepatocellular carcinoma after hepatectomy.Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo.The inflammatory response to stress and angiogenesis in liver resection for colorectal liver metastases: a randomized controlled trial comparing open versus laparoscopic approach.Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma.WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.Chronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular Carcinoma
P2860
Q26824909-EA3CB5F9-C6FB-4702-BF4A-F11254934F9DQ31120411-3F446AB0-7782-44D8-B82E-03E2E1C43045Q33600418-C73262A7-1DDC-405D-9F63-DED2AB9236E4Q33667127-39E936F9-7DB3-4340-89E0-D4B099A7FBC1Q33914603-642FD35C-F5DF-4CEA-8877-1596A3DFF504Q34542781-2C039CA2-0FF9-4BC6-B27A-C29C1888FD49Q35230282-10AEFB5C-A784-4576-AF22-7E7242D37D8DQ35570685-0D56C874-B4D4-4B24-BF5B-61CD2E917F10Q35843846-825270C4-801F-488A-ADB3-75AAD2CF59A2Q36675088-5F22BF28-34C0-423F-84A5-A9F05AE7BC7EQ36734211-8EDE99EF-C0FD-4239-B9F1-A7F5E980AFACQ36772115-ADA67135-0B66-4545-985F-805776CEA7CFQ36953993-C08BAF97-8A6A-4C53-B3DC-70BD77DE0B23Q37195560-47814C4F-8BC6-4EBB-A17E-07FD9389799CQ37385077-B64CEED0-9CCE-43AA-901B-F60C7EF8A37CQ37584674-E46A1CDC-5D6E-45BA-B55E-5C6D038132E9Q37871527-28FA4552-5B3B-4C8A-9BE2-10EC1D8AEB71Q37961603-6050F46F-2CB1-4960-AD94-11091E3972F6Q38440838-3892F081-07A4-4922-ADBB-9B9D93456196Q38685135-78BC5144-FFA4-4FAD-BA99-5543CD1F0848Q39099604-27BBF696-FE07-46A1-9713-A14CAB22E58FQ39642409-8074410D-0F96-4BAA-84DB-CCB6FD9F401AQ39815981-A3B9391C-886B-4B47-A8B6-C384EFF3F582Q40231652-2ED5627C-62C7-457C-B2D1-8230AAB67997Q40544130-4FEB1C09-6DC1-4614-BDD2-746ACE65585DQ41096812-25C2DD3C-3B2A-43E7-91BF-D513DD39F6C9Q41539096-05DC3A97-AE3D-4C2E-8C90-B55D4534568EQ43834815-BA155A1D-8DE9-41DF-A6A3-4EDB54A74AB2Q44656182-21C03AE9-7CCD-4793-88FE-1B214091724FQ44670065-9C171C0D-0B8C-49BC-A58E-6251488C2BD2Q45339888-0D36B5EE-0CF1-4E63-BF24-5160CDE31F0DQ45350842-1029D94D-9B89-405F-8335-688BB42FF979Q47139999-09BBA4FC-3ED0-46EC-9884-6349F082FBDDQ48725316-6A9EF8A3-B360-44A4-854E-6CEBAC325607Q48962335-43B4EBE9-BBC1-4336-A5FD-914976DCC2CCQ49043564-47AEAF23-518D-42C7-823E-897B728E097CQ52591520-4A6E4A1F-B1ED-42C4-8B0C-FD84D0B4AD3FQ54242413-AFF60266-5B8C-4A33-92F6-D9AC9265BE71Q55003004-67D730E3-20C5-4631-A5A8-51943A552811Q58689162-C15E465F-0153-4988-B509-E3B638482BA0
P2860
Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hypoxia-inducible factor-1 alp ...... tients with HCC after surgery.
@ast
Hypoxia-inducible factor-1 alp ...... tients with HCC after surgery.
@en
type
label
Hypoxia-inducible factor-1 alp ...... tients with HCC after surgery.
@ast
Hypoxia-inducible factor-1 alp ...... tients with HCC after surgery.
@en
prefLabel
Hypoxia-inducible factor-1 alp ...... tients with HCC after surgery.
@ast
Hypoxia-inducible factor-1 alp ...... tients with HCC after surgery.
@en
P2093
P2860
P356
P1433
P1476
Hypoxia-inducible factor-1 alp ...... tients with HCC after surgery.
@en
P2093
Bo-Heng Zhang
Chen-Xin Dai
Min-Jie Ju
Ming-Yan Cai
Shuang-Jian Qiu
Yong-Feng Xu
P2860
P2888
P356
10.1186/1471-2407-9-418
P407
P577
2009-12-01T00:00:00Z
P5875
P6179
1013054044